Xolair Sales
Current- Present Xolair to primary care physicians to build awareness of an NHLBI guideline treatment option for moderate to severe persistent allergic asthma.
- Guide physicians and staff to identify appropriate patient types and ask them to refer to pulmonologists and allergists.
- Maintain close working relationship with Genentech and Novartis counterparts to maximize impact and to most efficiently utilize resources.
- Continue to maintain relationships with pulmonologists and allergists.